Business Context and Reporting Period
This Form 6-K filing by Garden Stage Limited covers the month of January 2026, with a report date of January 15, 2026. The filing discloses the entry into a material agreement regarding a private placement of securities.
Key Financial Metrics
The filing does not provide historical revenue, profit, cash flow, margin, or debt figures. The primary financial metric disclosed relates to the proposed capital raise:
- Gross Proceeds: US$6 million
- Shares Issued: 47,961,831 Class A ordinary shares
- Subscription Price: US$0.1251 per share
- Par Value: US$0.0001 per share
Material Changes
On January 12, 2026, the Company entered into a Securities Purchase Agreement for a private placement. This represents a material change in the Company's capital structure pending closing. The transaction includes a 60-day lock-up restriction for the investors.
Guidance, Outlook, and Risks
Use of Proceeds: The Company intends to use the gross proceeds for general corporate purposes.
Closing Status: The Private Placement is expected to close by the end of January 2026, subject to the satisfaction or waiver of conditions precedent.
Risks and Forward-Looking Statements: The filing contains extensive forward-looking statements regarding market opportunities and performance metrics. Management disclaims any obligation to update these statements. Actual results may differ materially due to changes in business, market, financial, political, and legal conditions. Investors are directed to the "Risk Factors" section of the Company's Form 20-F filed on July 31, 2025, for a comprehensive list of risks.
Investor Verification Checklist
- Verify the final closing of the Private Placement and the actual receipt of US$6 million in proceeds.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific conditions precedent and covenants.
- Confirm the dilution impact of issuing 47,961,831 new shares on existing shareholders.
- Monitor the Company's Form 20-F (filed July 31, 2025) for detailed risk factors referenced in this filing.